Mikkael Sekeres - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Mikkael Sekeres's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Mikkael Sekeres

Mikkael Sekeres

Verified

Editorial Board, Blood Cancer Journal

Miami

Biography

Mikkael Sekeres is Professor of Medicine with Tenure and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine. He earned a medical degree and a master’s degree in clinical epidemiology from the University of Pennsylvania School of Medicine. Dr Sekeres completed his postgraduate training at Harvard University, finishing an internal medicine residency at Massachusetts General Hospital and a fellowship in hematology-oncology at the Dana-Farber Cancer Institute in Boston. He is chair of the medical advisory board of the Aplastic Anemia and Myelodysplastic Syndrome (MDS) International Foundation, and formerly chaired the Oncologic Drugs Advisory Committee of the F.D.A. Dr Sekeres’ research focuses on patients with MDS and older adults with acute myeloid leukemia, and he has been the national and international primary study investigator on dozens of phase I/II/III trials. He is the author or co-author of over 450 peer-reviewed manuscripts and 650 scientific abstracts. He was the inaugural editor-in-chief of the ASH Clinical News magazine; he is on the editorial board of several journals; has written over 100 essays for The New York Times, The Wall Street Journal, The Washington Post, Huffington Post, Slate, and The Hill, among others; and has authored 8 books, including When Blood Breaks Down: Life Lessons from Leukemia (The MIT Press 2020) and Drugs and the FDA: Safety, Efficacy, and the Public’s Trust (The MIT Press 2022).

Final Covers

Cancer Trials Fda Cancer Epidemiology

Doesn’t Cover

Business, Banking

Journalist Type

Seniority Positions

Industries

-

Medium Formats

Content

Total articles 356

  • Genome-wide methylome modeling via generative AI incorporating long- and short-range interactions

    By Fengyao Yan, Aristeidis G Telonis, Qin Yang, Limin Jiang, Francine E Garrett-Bakelman, Mikkael Sekeres, Valeria Santini, Michele Ceccarelli, Neha Goel, Liliana Garcia-Martinez, Lluis Morey, Maria Figueroa, Yan Guo| Science Magazine Verified

    By Fengyao Yan, Aristeidis G Telonis, Qin Yang, Limin Jiang, Francine E Garrett-Bakelman, Mikkael Sekeres, Valeria Santini, Michele Ceccarelli, Neha Goel, Liliana Garcia-Martinez, Lluis Morey, Maria Figueroa, Yan Guo · Science Magazine

    Apr. 11, 2025

  • Is drinking just a little alcohol OK? Here’s a cancer expert’s verdict

    By Mikkael Sekeres| Australian Financial Review Verified Apr 1, 2025 – 7.53am or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? My patients – and my family and friends – often ask me what they can do to reduce their risk of cancer. I’m an oncologist and a cancer epidemiologist, which means I investigate patterns and causes of cancers.

    By Mikkael Sekeres · Australian Financial Review

    Mar. 31, 2025

  • We asked an oncologist: Is it okay to drink just a little bit of alcohol?

    By Mikkael Sekeres| New Zealand Herald Verified Does casual drinking increase the risk of cancer? Photo / 123RFAs more people choose to drink less, here’s what to know about the research on alcohol and cancer risk. My patients – and my family and friends – often ask me what they can do to reduce their risk of cancer. I’m an oncologist and a cancer epidemiologist, which means I investigate patterns and causes of cancers.

    By Mikkael Sekeres · New Zealand Herald

    Mar. 30, 2025

As seen in

Company Info

Blood Cancer Journal

Hoboken, New Jersey, United States

'+1 201-748-6000